Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vismodegib in Operable Basal Cell Carcinoma
NCT01201915Phase 2Completed
- Sponsor
- Genentech
- Start
- Oct 2010
- Primary completion
- May 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of vismodegib in basal cell carcinoma (BCC), sponsored by Genentech. Started Oct 2010; status: completed.
02
Drugs
vismodegib
03
Conditions
basal cell carcinoma (BCC)
Beyond the preview
Go deeper on NCT01201915.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01201915.